Evidence map›Paper›PMID 31522023›Full record

ArticleColloids and surfaces. B, Biointerfaces2019

Light-activated doxorubicin-encapsulated perfluorocarbon nanodroplets for on-demand drug delivery in an in vitro angiogenesis model: Comparison between perfluoropentane and perfluorohexane.

Zheng Yuan, Alec Demith, Ryan Stoffel, Zhe Zhang, Yoonjee C Park

Open access · greenAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Colloids and surfaces. B, Biointerfaces, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zheng YuanDepartment of Chemical & Environmental Engineering, College of Engineering & Applied Sciences, USA.
Alec DemithMedical Sciences Program, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
Ryan StoffelDepartment of Chemical & Environmental Engineering, College of Engineering & Applied Sciences, USA.
Zhe ZhangDepartment of Chemical & Environmental Engineering, College of Engineering & Applied Sciences, USA.
Yoonjee C ParkDepartment of Chemical & Environmental Engineering, College of Engineering & Applied Sciences, USA. Electronic address: parkye@ucmail.uc.edu.
Park University · USUniversity of Cincinnati Medical Center · US

Funding

KL2 Training ProgramKL2TR001426 · NCATS · UNIVERSITY OF CINCINNATI · PI ZELLER, MARGARET H · 2015 to 2024
$6.8M
NCATS NIH HHS KL2 TR001426
6 · The paper itself

Abstract

Phase-transition perfluorocarbon (PFC) nanodroplets have been developed for on-demand drug delivery carriers with external triggers such as ultrasound or laser irradiation techniques. Although various perfluorocarbons, including perfluoropentane (C

Indexed as

Antibiotics, AntineoplasticBlood VesselsCells, CulturedDoxorubicinDrug CompoundingDrug Delivery SystemsFluorocarbonsGoldHumansHuman Umbilical Vein Endothelial CellsLightNanotubesPentanesPhase TransitionAntibiotics, AntineoplasticDoxorubicinFluorocarbonsGoldPentanesperflexaneperfluoropentaneAngiogenesis modelLight-activated drug deliveryPerfluorocarbon nanodropletPhase-transition

Identifiers

PMID31522023
PMCPMC6881552
OpenAlexW2971693375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.